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Abstract
Two critical issues in forensic science are identifying body fluid traces found at crime scenes and
preserving them for DNA analysis. However, the majority of current biochemical tests for body
fluid identification, which are applicable at the crime scene, are presumptive and destructive to
the sample. Raman Spectroscopy provides a suitable alternative to current methods as a
nondestructive, confirmatory, and potentially in field method. Our laboratory has developed a
chemometric model for the identification of five main body fluids using Raman spectroscopy.
This model was developed using samples obtained from healthy donors. Thus, it is of most
importance for the forensic application of the method to validate its performance for donors with
diseases that might affect the biochemical composition of body fluids. In this study, the
developed method was validated using peripheral blood samples acquired from donors with
Celiac Disease, Sickle Cell Anemia, and Type 2 Diabetes. It was shown that the method
correctly identified all samples as peripheral blood indicating that no false positives could occur
because the blood traces were originated from donors suffering from the diseases.
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Introduction
The identification of body fluid stains found at crimes scenes is a major component of
forensic investigations. Knowledge of the identity and origin of such evidence can provide
important context about a crime. Further, body fluids can provide important information about
potential victims and suspects, such as race or gender [1, 2]. Most notably, DNA evidence can be
collected from body fluids stains and used for personal identification [3]. Recent work has also
looked into using body fluid stains to deduce the time since their deposition, and thus, the
approximate time of the crime [4]. Considering the wealth of information that can be extracted
from a single body fluid stain, it is important that suitable body fluid identification tests are
accessible to analyst. Ideally, such a test could be universally applied to all body fluids, used in
the field, and wouldn’t destroy the often, little amount of sample found at the crime scene.
Further, such a test should be confirmatory, meaning it doesn’t yield false negatives (a negative
result that is actually positive) or false positives (a positive result that is actually negative).
Methods that forensic analyst currently use contain many of these characteristics and
offer a robust analysis of body fluids, however, they often fall short of the ideal. Presumptive
chemical tests that can be used in the field, such as Kastle Meyers test, are quite sensitive.
However, they aren’t awfully specific and can yield false positive results for a variety of
common household substances and forensically relevant materials like denim, as well as false
negatives [5, 6]. Thus, confirmatory analysis is required in the lab to ensure that blood is present.
Confirmatory tests for blood like the Takayama and Teichman test are effective in their selective
identification of blood but are destructive in nature [7]. More often, forensic analyst may go
directly for DNA analysis to confirm the presence of human blood. While this method is direct

1

and confirmatory, it must be conducted in a lab setting as opposed to in the field and can be
timely [3].
Raman spectroscopy can potentially serve as an alternative to these methods and remedy
these shortcomings. It has a number of uses in forensic science [8]. Paring Raman spectroscopy
with chemometric analysis can allow for the confirmatory identification of body fluids, even in
the presence of some contaminants [9, 10]. The advantages don’t stop here. Raman spectroscopy
is non-destructive; thus, it won’t consume the trace amount of sample being analyzed. Further,
this method can be universally applied to several body fluids, as opposed to using a specific test
to search for each type of body fluids [9, 11]. This universal approach can save both money and
time. Finally, recent advancements have allowed for the creation of portable Raman
spectrometers, meaning that there is a possibility for use in the field.
Having acknowledged the many advantages provided by the use of Raman spectroscopy
for the analysis of body fluid stains, our laboratory has developed a novel method that can
identify the five main body fluids (peripheral blood, semen, saliva, sweat, and vaginal fluid)
from their Raman spectra using a machine learning model [9]. This method, outlined in Muro et
al., 2016, uses a support vector machine discriminant analysis model with genetic algorithm.
This method was shown to have 100% success in the analysis of external validation samples.
While this method has already been shown to have remarkable promise for the more
efficient analysis of body fluid stains, it still needs thorough validation before practical
application by law enforcement agencies. Notably, the model used in this method was
constructed using body fluid spectra from samples that came from healthy donors. There are a
host of diseases that can affect the biochemical composition of body fluids, which in turn could
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affect their Raman spectra, and the ability of the model to identify the body fluid correctly. Thus,
to ensure the forensic relevance of this method, potential false negatives arising from diseases
that could affect the biochemical composition of a body fluid must be evaluated.
In this paper, the effect of blood-affecting diseases on the ability of the model to identify
peripheral blood was evaluated. The chosen blood-affecting diseases have already been shown to
pose a potential risk for false negatives due to their Raman spectra’s dependance on the disease.
While this is useful for disease diagnostics, it can complicate forensic analysis. The first bloodaffecting disease, Celiac disease, is an autoimmune disorder where in individual’s small intestine
will damage themselves if they don’t remove gluten from their diet. This disorder effects 1 in
100 people world-wide [12]. Ralbovsky & Lednev have shown that blood from donors with
Celiac Disease differs from that from healthy donors on a gluten-free diet [12].
The Raman spectra of blood has also been shown to be affected by whether or not an
individual has Sickle Cell Anemia. This genetic disorder is characterized by abnormal
hemoglobin, such as Hemoglobin S, which arises due to the replacement of glutamic acid with
valine in the hemoglobin β amino acid chain [13]. As a result of the abnormal hemoglobin, the
red blood cell forms a sickle shape. This can cause a variety of complications such as high blood
pressure or even heart failure [14]. The changes seen in the Raman spectra of Sickle Cell Anemia
blood can be explained by differences in hemoglobin. As it dominates the Raman spectra of
blood, differences in hemoglobin can have such an effect on the overall Raman spectra [13, 14].
Type 2 Diabetes is a condition characterized by abnormally high glucose levels in the
blood due to scarce or ineffective insulin, which can lead to severe complications such as organ
failure [15]. This particular type of diabetes is the most prevalent form with 8.6% of American
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adults having Type 2 diabetes compared to 0.55% of the same population having Type 1 diabetes
[16]. The Raman spectra of blood from donors with Diabetes has also been shown to differ from
healthy controls. This could be due to several biomarkers of the disease, such as Hemoglobin
A1c [15].
In this study, the validation of the Raman spectroscopic method for the identification of
body fluid traces was validated with respect to potential false negatives caused by blood
effecting diseases; Celiac Disease (CD), Sickle Cell Anemia (SCA), and Type 2 Diabetes (D2).
Methods
A. Samples
Whole blood samples from 10 donors with CD, 3 donors with SCA, 4 donors with D2,
and 1 donor with both SCA and D2 were purchased from BioIVT, Inc. (Westbury NY). The
donors were chosen such that there was variety in age, sex, and race. This is with the exception
of the race of SCA donors, who were all African American. The samples were stored in a -80°C
freezer until use. Upon use, the samples were thawed, and 5 μL of the whole blood was
deposited onto an aluminum covered glass slide. The slide was stored in a petri dish to prevent
contamination and allowed to dry overnight.
B. Instrumentation
The Raman spectra of the blood samples were collected using an inVia Raman
spectrometer (Renishaw, Inc. Hoffman Estate, IL) with WiRE 3.2 software and a Lecia research
grade microscope. Prior to sample collection, the spectrum of a silicon standard was collected to
ensure the instrument was properly calibrated. A 20x objective was used to focus the laser beam
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onto the samples. A 785 nm excitation wavelength was used at a laser power of 5%. For each
spectrum, 20 ten-second accumulations were collected over a 300 – 1800 cm-1 range. 10-20
spectra were collected from different points within the same bloodstain using automatic mapping
to account for intrasample variability. These parameters aligned with those used to record the
Raman spectra of healthy blood used to construct the model developed in Muro et al., 2016.
C. Statistical Analysis
Cosmic rays were first removed from the Raman spectra of the blood samples in the
WIRE 3.2 software. After, the spectra were preprocessed in MATLAB (MathWorks inc., Natick,
MA) using the PLS Toolbox extension (Eigenvector Research, Wenatchee, WA). In accordance
with the preprocessing used in Muro et al., 2016, the spectra were first baseline corrected using
automatic weighted least squares, 5th order polynomial. Then the spectra were normalized by
total area. After preprocessing, each group of spectra were analyzed using the Support Vector
Machine Discriminant Analysis (SVMDA) model with Genetic Algorithm (GA) created in Muro
et al., 2016. The model predicted which body fluid class (if any) the spectra belonged to and
displayed it in a confusion matrix along with the actual body fluid class of the spectra.
Results and Discussion
This study sought to further validate a previously developed body fluid identification
model based on Raman spectroscopy by investigating the potential for false negatives caused by
blood-affecting diseases. In this study, 213 Raman spectra were collected from 18 peripheral
bloodstains obtained from donors with various blood-affecting diseases.
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Figure 1
Average Spectra by Disease Group

Note. This figure shows the average preprocessed Raman spectra of peripheral bloodstains for the healthy peripheral
blood used to test the study’s protocol (black) and each of the disease groups (Celiac Disease – blue, Sickle Cell
Anemia – green, Type 2 Diabetes – red).

Peripheral blood from donors with CD, SCA, and D2 were evaluated in this study. The
average preprocessed Raman spectra for each disease are displayed in Figure 1, alongside the
average preprocessed Raman spectra collected from healthy controls that was used to test this
study’s protocols. The spectra exhibit remarkable similarity upon visual examination. Still, given
the subjective and non-computational nature of visually evaluating spectra, analysis using the
statistical model is necessary to ensure that the blood-affecting diseases won’t contribute to false
negatives.
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Figure 2
Excluded Celiac Disease Raman Spectra

Note. This figure shoes the Celiac disease Raman spectra excluded from the analysis based on visual inspection.

Prior to analysis using the SVMDA model, the Raman spectra were preprocessed in the
same manor that the spectra used to build the model were. Then, each disease group was
evaluated by the model. While 100 CD spectra were collected, 95 were preprocessed and
analyzed using the model, as 5 of the Raman spectra were excluded from the data set. Figure 2
shows the five spectra that were excluded based on visual inspection. These spectra exhibited
excessive noise, or exorbitant amounts of cosmic rays. The obstruction by the noise/cosmic rays
was evident from the visual examination and justified the removal of these spectra from further
consideration, leaving 95 spectra to be analyzed by the model. Of the 95 CD spectra analyzed, all
95 were correctly identified as peripheral blood.

7

For the other two diseases evaluated, SCA and D2, no spectra were excluded from
preprocessing and analysis with the model. Thus, 52 SCA spectra and 75 D2 spectra were
analyzed. It should be noted that one sample, for which 14 spectra were collected, is double
counted for these two disease groups, as the donor had both diseases. All of the SCA and D2
spectra were correctly identified by the model as peripheral blood.
The model was successful in identifying the 208 spectra resulting in 100% accuracy. The
correct classification of all the spectra means that the model exhibited no false negatives despite
analyzing samples from donors with blood-affecting diseases. These findings suggest that the
analyzed diseases don’t pose a risk for causing false negatives. This could be attributed to the
fact that at the excitation wavelength used for analysis, 785 nm, the Raman spectra of blood is
dominated by hemoglobin. Some of the diseases do influence hemoglobin, such as SCA which is
caused by the atypical hemoglobin S molecule. However, the results suggest that the
composition of these hemoglobin molecules and healthy hemoglobin are largely the same. While
the difference between the two may be enough to result in functional differences and
differentiation when a model is trained to do so, their Raman spectra are similar enough to still
allow for the analyzed blood-affecting disease blood to be correctly identified.
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Conclusion
Body fluid traces remain a crucial piece of evidence for forensic investigations, making
the identification and preservation of this type of evidence of the upmost importance. While
current methods for the identification of body fluids often require further testing and destroy the
evidence in question, Muro et al. has taken a step towards the development of a universal, nondestructive, and confirmatory body fluid identification method. This method, which uses Raman
spectroscopy paired with SVMDA and GA, has proven to be highly effective for the
identification of the five main body fluids (peripheral blood, semen, vaginal fluid, sweat, and
saliva). As samples from healthy controls were used to construct and validate the method, to
ensure its confirmatory nature, the potential for false negatives caused by blood-affecting
diseases was evaluated. It was investigated whether the method could correctly identify
peripheral blood that came from donors who have CD, SCA, and D2. The method correctly
classified all the analyzed peripheral blood spectra, thus achieving 100% accuracy. This finding
suggests that the presence of the blood-affecting diseases don’t result in false negatives for this
method.
The findings of this study further demonstrate Raman spectroscopy’s potential to be used
as a non-destructive and confirmatory method for the forensic identification of body fluids. In
order for the method that was validated in this study to be considered confirmatory, it would
need to have little to no risk of false negatives. The findings presented in this study support the
confirmatory nature of Raman spectroscopy paired with chemometric analysis as the presence of
blood-affecting diseases didn’t result in false negatives. Still, before this method can be widely
used by analyst in the field, there are other matters worth investigating. Other body fluid
effecting diseases are worth examining, especially for the other main body fluids. Thus far, a
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2018 study by Fikiet et al. examined the potential for azoospermia to cause false negatives for
semen identification [17]. Other potential sources of false negatives should also be investigated,
such as the reagents used for the preliminary detection of bloodstains at the scene of the crime,
like luminol or fluorescein. Such investigations would push this method one step closer to
becoming the non-destructive and confirmatory universal body fluid identification method
forensic science needs.
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